Kolon TissueGene has filed a notice of an exempt offering of securities to raise $30,000,024.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Kolon TissueGene is raising $30,000,024.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Moon Noh played a key role…